Additionally, a greater fraction of lung gp33-specific CD8+ T cells expressed Granzyme B in treated mice (Fig. 3i), suggesting improved effector function within the tumor-specific CD8+ T cell population. This evidence concerns the gene CD8A and neoplasm.